Healthcare -
Biotechnology - NASDAQ - US
$ 0.1698
-5.67 %
$ 82.8 M
Market Cap
None
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Reviva Pharmaceuticals Holdings, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 39.5 |
| Operating Income | (39.5) |
| Other Expenses | (39.5) |
| Net Income | -39.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Feb-2020 | Feb-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 0 | 0 | 0.7 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | (0.7) | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 39 503 636.0 | 24.3 | 10.1 | 2.4 | 0.4 | 1.1 |
| Selling, General and Administrative Expenses | 8 083 819.0 | 5.4 | 5.3 | 2.1 | 0.2 | 0.2 |
| Research and Development Expenses | 31 419 817.0 | 18.9 | 4.9 | 0.3 | 0.2 | 0.9 |
| Operating Income | (39 503 636.0) | (24.3) | (10.1) | (2.4) | (0.4) | (1.1) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0.2 | 2.41 K | 1.5 | 0.5 | 0 |
| Total Other Income | 39 503 596.8 | 11.9 K | 1.6 | (1.3) | (0.5) | (0.6) |
| Pre-Tax Income | (39.2) | (24.3) | (8.5) | (3.8) | (0.8) | (1.7) |
| NET INCOME | ||||||
| Tax Provision | (16 949.0) | 20.8 K | 6 K | 800 | 800 | 800 |
| Net Income | (39 260 837.0) | (24.3) | (8.5) | (3.8) | (0.8) | (1.7) |
| EPS | 1.65 | 1.25 | 0.58 | 1.24 | 0.31 | 0 |